Resveratrol- and melatonin-abated ovariectomy and fructose diet-induced obesity and metabolic alterations in female rats

Menopause

Volumn 21, Issue 8, 2014, Pages 876-885

  Majumdar, Anuradha Sandeep ^a   Giri, Priti R ^a   Pai, Sarayu A ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Fructose diet; Melatonin; Obesity; Ovariectomy; Resveratrol

Indexed keywords

CHOLESTEROL; FATTY ACID; FRUCTOSE; GLUCOSE; INSULIN; MELATONIN; RESVERATROL; TRIACYLGLYCEROL; ANTIOXIDANT; STILBENE DERIVATIVE;

ABDOMINAL FAT; ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN SYNTHESIS; EXPERIMENTAL OBESITY; FATTY ACID BLOOD LEVEL; FEMALE; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HYPERINSULINEMIA; HYPERTROPHY; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER; LIVER HISTOLOGY; LIVER WEIGHT; MACROPHAGE; MACROPHAGE MIGRATION; METABOLIC DISORDER; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OVARIECTOMY; POSTMENOPAUSE; RAT; RETROPERITONEAL FAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DIABETES MELLITUS; DIET; DISEASE MODEL; OBESITY; ORAL DRUG ADMINISTRATION; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS; DIET; DISEASE MODELS, ANIMAL; FEMALE; FRUCTOSE; MELATONIN; OBESITY; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84904970870     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000187     Document Type: Article

References (74)

1. Milewicz A, Tworowska U, Demissie M. Menopausal obesityVmyth or fact? Climacteric 2001;4:273-283
2. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006;116:561-570
3. Epstein FH, Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811
4. Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 2002;81:603-611
5. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Simone LD, Genazzani A. Climacteric modifications in body weight and fat tissue distribution. Climacteric 1999;2:37-44
6. Bantle JP. Dietary fructose and metabolic syndrome and diabetes. J Nutr 2009;139:1263S-1268S.
7. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol 2010;299:E685-E694
8. Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:499-503
9. Steinkellner AR, Denison SE, Eldridge SL, Lenzi LL, Chen W, Bowlin SJ. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Womens Health Initiative. Menopause 2012;19:616-621
10. Ettinger B, Wang SM, Leslie RS, et al. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause 2012;19:610-615
11. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360: 942-944
12. Szkudelska K, Szkudelski T. Resveratrol, obesity and diabetes. Eur J Pharmacol 2010;635:1-8
13. Rivera L, Moron R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009;77:1053-1063
14. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-342
15. Price NL, Gomes AP, Ling AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 2012;15:675-690
16. Tempfer CB, Froese G, Heinze G, Bentz E-K, Hefler LA, Huber JC. Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med 2009;122:939-946
17. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 2010;54:7-16
18. Lin YC, Hsiao TJ, Chen PC. Persistent rotating shift-work exposure accelerates development of metabolic syndrome among middle-aged female employees: a five-year follow-up. Chronobiol Int 2009;26:740-755
19. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005;308:1043-1045
20. Lima FB, Machado UF, Bartol I, et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am J Physiol 1998;275:E934-E941
21. La Fleur SE, Kalsbeek A, Wortel J, Van Der Vliet J, Buijs RM. Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. J Neuroendocrinol 2001;13:1025-1032
22. Bartness TJ, Demas GE, Song CK. Seasonal changes in adiposity: the roles of the photoperiod, melatonin and other hormones, and sympathetic nervous system. Exp Biol Med 2002;227:363-376
23. Bartness TJ, Wade GN. Photoperiodic control of seasonal body weight cycles in hamsters. Neurosci Biobehav Rev 1986;9:599-612
24. Morgan L, Arendt J, Owens D, et al. Effects of the endogenous clock and sleep time on melatonin, insulin, glucose and lipid metabolism. J Endocrinol 1998;157:443-451
25. Magri F, Sarra S, Cinchetti W, et al. Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J Pineal Res 2004;36:256-261
26. Prunet-Marcassus B, Desbazeille M, Bros A, et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003;144:5347-5352
27. Kitagawa A, Ohta Y, Ohashi K. Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 2012;52:403-413
28. Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter depression: a pilot study. Psychiatry Res 1998;77:57-61
29. Majumdar AS, Joshi PA, Giri PR. Resveratrol attenuated smokeless tobacco induced vascular and metabolic complications in ovariectomized rats. Menopause 2013;20:869-876
30. Puchalski SS, Green JN, Rasmussen DD. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. Endocrine 2003;21:163-167
31. Rasmussen DD, Boldt BM, Wilkinson C, Yellon SM, Matsumoto AM. Daily melatonin administration at middle age suppresses male rate visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999;140:1009-1012
32. Ŕos-Lugo MJ, Cano P, Jiménez-Ortega V, et al. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fatYfed rats. J Pineal Res 2010;49:342-348
33. Wolden-Hanson T, Mitton D, McCants R, et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000;141:487-497
34. Zanuto R, Siqueira-Filho MA, Caperuto LC, et al. Melatonin improves insulin sensitivity independently of weight loss in old obese rats. J Pineal Res 2013;55:156-165
35. Sanchez-Mateos S, Alonso-Gonzalez C, Gonzalez A, et al. Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats. Maturitas 2007;58:91-101
36. Novelli E, Diniz Y, Galhardi C, et al. Anthropometrical parameters and markers of obesity in rats. Lab Anim 2007;41:111-119
37. Picardi A, de Oliveira AC, Muguerza B, et al. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol 1997;26:191-202
38. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475
39. Lott JA, Turner K. Evaluation of Trinders glucose oxidase method for measuring glucose in serum and urine. Clin Chem 1975;21:1754-1760
40. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-482
41. Renuka T, Robinson R, Paulose C. Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro. Neurochem Res 2006;31:313-320
42. Falholt K, Lund B, Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 1973;46:105-111
43. Coope G, Atkinson A, Allott C, et al. Predictive blood glucose lowering efficacy by glucokinase activators in high fat fed female Zucker rats. Br J Pharmacol 2006;149:328-335
44. Poudyal H, Campbell F, Brown L. Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrateY, high fatYfed rats. J Nutr 2010;140:946-953
45. Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101:1354-1361
46. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411
47. Galipeau D, Verma S, McNeill JH. Female rats are protected against fructose-induced changes in metabolism and blood pressure. Am J Physiol Heart Circ Physiol 2002;283:H2478-H2784
48. Linden A, Uvnas-Moberg K, Forsberg G, Bednar I, Södersten P. Involvement of cholecystokinin in food intake, 3: oestradiol potentiates the inhibitory effect of cholecystokinin octapeptide on food intake in ovariectomized rats. J Neuroendocrinol 1990;2:797-801
49. Koshy SM, Bobby Z, Hariharan AP, Gopalakrishna SM. Amla (Emblica officinalis) extract is effective in preventing high fructose dietYinduced insulin resistance and atherogenic dyslipidemic profile in ovariectomized female albino rats. Menopause 2012;19:1146-1155
50. Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2011;12: 167-188
51. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study [article retracted]. Ann Intern Med 1995;123:673-675
52. Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-F. Nature 2004;429:771-776
53. Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 2010;110:1307-1321
54. Baile CA, Yang JY, Rayalam S, et al. Effect of resveratrol on fat mobilization. Ann N Y Acad Sci 2011;1215:40
55. Lindqvist A, Baelemans A, Erlanson-Albertsson C. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul Pept 2008;150:26-32
56. Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005;280:17187-17195
57. Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010;90:23-46
58. Breen DM, Sanli T, Giacca A, Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 2008;374:117-122
59. Kalaany NY, Gauthier KC, Zavacki AM, et al. LXRs regulate the balance between fat storage and oxidation. Cell Metab 2005;1:231-244
60. Hoyos M, Guerrero JM, Perez-Cano R, et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000;28:150-155
61. yener G, Balkan J, evikbaz U, Keyer-Uysal M, Uysal M. Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL/6J mice. J Pineal Res 2004;36:212-216
62. Macdonald I. Influence of fructose and glucose on serum lipid levels in men and pre-and postmenopausal women. Am J Clin Nutr 1966;18: 369-372
63. Wang GL, Fu YC, Xu WC, Feng YQ, Fang SR, Zhou XH. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem Biophys Res Commun 2009;380: 644-649
64. Chen X, Zhang C, Zhao M, et al. Melatonin alleviates lipopolysaccharideinduced hepatic SREBP-1c activation and lipid accumulation in mice. J Pineal Res 2011;51:416-425
65. Teff KL, Elliott SS, Tschöp M, et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 2004;89: 2963-2972
66. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000;11:351-356
67. Wakatsuki A, Okatani Y, Ikenoue N, Kaneda C, Fukaya T. Effects of short-term melatonin administration on lipoprotein metabolism in normolipidemic postmenopausal women. Maturitas 2001;38:171-177
68. Fischer-Posovszky P, Kukulus V, Tews D, et al. Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am J Clin Nutr 2010;92:5-15
69. Yang JY, Della-Fera MA, Rayalam S, et al. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci 2008;82:1032-1039
70. Alonso-Vale MIC, Peres SB, Vernochet C, Farmer SR, Lima FB. Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPA transcriptional activity. J Pineal Res 2009;47:221-227
71. Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 2005;42:880-885
72. Guebre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, Diehl AM. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 2000;31:633-640
73. Cuesta S, Kireev R, Forman K, et al. Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8). Exp Gerontol 2010;45:950-956
74. Jeon BT, Jeong EA, Shin HJ, et al. Resveratrol attenuates obesityassociated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012;61:1444-1454.